drugset / Trial / NCT00992017

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

NCT00992017 ↗

NaSingle-groupOpen-labelPrevention

Summary

Both pregnant women and people infected with HIV are at increased risk of viral infection, including influenza infection. Pregnant women infected with HIV may be at particular risk of infection from the new H1N1 influenza virus. This study tested the safety and immunogenicity of an H1N1 influenza vaccine in pregnant women infected with HIV.

Timeline

Start
2009-10
Primary completion
2010-11
Completion
2010-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza A (H1N1) monovalent vaccine Vaccine 30 ug Intramuscular